Consistent with these observations, tumors formed from subcutaneous engraftments of GFP-LC3-RFP-LC3ΔG-expressing A549 cells exhibited a lower GFP/RFP ratio in the invasive front at the tumor-stroma border than inside the tumor body (Figure 3D). The gene discussed is MAP1LC3A; the disease is neoplasm.